Peritonitis: Symptoms and Treatment
Clinical Presentation
Peritonitis presents with abdominal pain and tenderness in 74-95% of patients, typically accompanied by rebound tenderness and guarding, which are the hallmark physical examination findings. 1
Key Symptoms
- Abdominal rigidity strongly suggests peritonitis and is a critical diagnostic finding 1
- Tachycardia occurs in 62.5% of patients 1
- Fever greater than 38.5°C is present in 38% of cases 1
- Decreased or absent bowel sounds are commonly observed 1
- Ileus symptoms including vomiting and absence of defecation may develop 1
- Hemodynamic instability and shock can occur, particularly in diffuse peritonitis 1
- Abdominal distension is seen in 6.6% of patients 1
- Rectal bleeding occurs in 15% of cases 1
Laboratory Findings
- Leukocytosis with left shift (band neutrophils >20%) is characteristic 1
- Elevated C-reactive protein (CRP) levels 1
- Increased serum lactate levels indicate ongoing sepsis 1
- Elevated serum creatinine (>50% above baseline) may be present 1
- For spontaneous bacterial peritonitis (SBP): ascitic fluid neutrophil count >250/mm³ is diagnostic 1
- For secondary peritonitis: low ascitic fluid glucose (<50 mg/dL) and multiple organisms on culture suggest gastrointestinal perforation 1, 2
Imaging Findings
- CT scan is the imaging modality of choice for stable patients not requiring immediate surgery, showing free fluid and air, bowel wall thickening, and pericolic inflammation 3, 1
- Free air on plain abdominal radiograph indicates perforation but has lower sensitivity 1
- Ultrasound can identify free fluid in resource-limited settings 1
Treatment Approach
Immediate Resuscitation
Patients with peritonitis require rapid restoration of intravascular volume and physiological stability, with resuscitation beginning immediately upon diagnosis. 3
- For septic shock: fluid resuscitation must begin immediately when hypotension is identified 3
- For stable patients: intravenous fluid therapy should begin when intra-abdominal infection is first suspected 3
Antimicrobial Therapy
Antimicrobial therapy should be initiated once peritonitis is diagnosed or strongly suspected, with antibiotics administered as soon as possible in patients with septic shock. 3
Empiric Antibiotic Regimens
For community-acquired peritonitis (mild-to-moderate severity):
- Single agents: Ertapenem, moxifloxacin, tigecycline, or ticarcillin-clavulanate 3
- Combination therapy: Cefazolin, cefuroxime, ceftriaxone, cefotaxime, ciprofloxacin, or levofloxacin, each combined with metronidazole 3
For high-risk or severe peritonitis:
- Single agents: Imipenem-cilastatin, meropenem, doripenem, or piperacillin-tazobactam 3
- Combination therapy: Cefepime, ceftazidime, ciprofloxacin, or levofloxacin, each combined with metronidazole 3
For spontaneous bacterial peritonitis:
- Third-generation cephalosporins (cefotaxime 2g IV every 8 hours) are first-line 1, 4
- Albumin infusion (1.5 g/kg at diagnosis, 1 g/kg on day 3) reduces renal failure and mortality 4
Piperacillin-tazobactam is FDA-approved for peritonitis caused by beta-lactamase producing E. coli or Bacteroides fragilis group at 3.375 grams every 6 hours for 7-10 days 5
Source Control
Patients with diffuse peritonitis should undergo emergency surgical intervention as soon as possible, even if resuscitation measures need to be continued during the procedure. 3
Surgical Approach
- Emergency surgery is required for diffuse peritonitis with signs of generalized contamination 3
- Source control procedures include drainage of infected foci, control of ongoing contamination, resection or repair of perforated viscus, and debridement of necrotic tissue 1
- Percutaneous drainage is preferable to surgical drainage for well-localized abscesses when feasible 3
- For hemodynamically stable patients without acute organ failure, intervention may be delayed up to 24 hours if appropriate antibiotics are given and close monitoring is provided 3
Critical Timing Considerations
Delay in diagnosis and treatment significantly increases mortality rates—each minute counts in peritonitis management. 1, 6, 7
- Delayed source control beyond 24 hours results in higher mortality 3, 6
- Inadequate source control is associated with intolerably high mortality rates 3, 1
- Early re-laparotomy appears most effective for postoperative peritonitis 3
Special Populations
For highly selected patients with minimal physiological derangement and well-circumscribed infection (periappendiceal or pericolonic phlegmon), antimicrobial therapy alone may be considered with very close clinical follow-up 3
For postoperative peritonitis: prompt surgical source control should be performed following diagnosis, as this population shows particularly high mortality due to nonspecific symptoms 3, 7
Duration of Treatment
- Community-acquired peritonitis: 7-10 days of antibiotic therapy 5
- Nosocomial peritonitis: 7-14 days of treatment 5
- Tuberculous peritonitis: 6-month regimen with first-line anti-tuberculous agents if suspected 4
Common Pitfalls
- Do not delay surgery in patients with diffuse peritonitis for additional imaging—obvious signs of peritonitis warrant immediate intervention 3
- Do not obtain routine blood cultures for community-acquired peritonitis unless the patient appears clinically toxic or is immunocompromised 3
- Consider tuberculous peritonitis in patients with lymphocytic-predominant ascites, particularly in endemic areas or immunocompromised patients (ADA >32-40 U/L has 100% sensitivity) 4, 2
- Multiple organisms on ascitic fluid culture suggest secondary rather than primary peritonitis and require surgical evaluation 1, 2